MedTrace Logo

Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit (Firefly Sheffield)

NCT02785588 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2019-09-13

Study results available
· View outcomes & findings →

Summary

This study investigates a novel magnetic resonance imaging (MRI) system designed by GEHC for imaging viable neonate and infant populations. This MR system has a smaller size and design features that may make it more feasible to locate the system in close proximity to care areas for neonates (birth - 1 month) and infants (\>1 month to two years), such as clinical neonatal intensive care units (NICUs) and other infant and neonatal care departments.

Conditions

  • Neonatal Neuroimaging

Interventions

DEVICE

3.0 T Neonatal MRI scanner

eligible subjects will undergo neonatal MRI scan procedure

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER

  • GE Healthcare

    lead INDUSTRY

Principal Investigators

  • Paul Griffiths, MD, PhD · University of Sheffield

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Minute
Max Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-22
Primary Completion
2017-08-20
Completion
2018-04-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02785588 on ClinicalTrials.gov